Nectar Lifesciences Limited
Incorporated in 1995, Nectar LifesciencesLtd manufactures APIs and Formulationsand is also in the Menthol business
What Nectar files
- Others78
- Updates20
- Important20
- Board Meeting12
- Dividend/Bonus7
- Results4
Nectar Lifesciences will hold its 31st Annual General Meeting virtually on September 18. Shareholders can access the Annual Report 2025-26 and AGM notice online. E-voting will be available from September 15 to 17 for shareholder participation.
Nectar Lifesciences has changed its corporate office to "Godrej Eternia," West Wing (Tower A), Plot No. 70, Industrial Area, Phase-1, Chandigarh. This operational move has been approved by the board.
Nectar Lifesciences divested non-core assets, selling its inoperative Narbada Industries unit's land, structures, and machinery for 11.22 Cr. This strategic move liquidates idle assets, enhancing focus.
Nectar Lifesciences extended the deadline for the slump sale of its Empty Hard Gelatin Capsule business to December 31, 2026. This operational update defers the potential asset monetization.
Nectar Lifesciences has shifted its registered office to a new address within the same city. This administrative change does not impact the company's operations or statutory registrations.